We commenced operations in 1985 and are an innovative developer and manufacturer of needle-free injection therapy systems (“NFITS”). Our NFITS work by forcing liquid medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure medication that penetrates the skin, depositing the medication in the tissue beneath. By bundling customized needle-free delivery systems with partners’ injectable medications and vaccines, we can enhance demand for these products in the healthcare provider and end-user markets.
Company profile
Ticker
BJCT
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BIOJECT MEDICAL SYSTEMS LTD
SEC CIK
Corporate docs
IRS number
931099680
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
5 Apr 16
8-K
Bioject Reports Unaudited Third Quarter 2015 Financial Results
27 Nov 15
8-K
Bioject Reports Unaudited Second Quarter 2015 Financial Results
14 Aug 15
NT 10-Q
Notice of late quarterly filing
14 Aug 15
8-K
Bioject Reports Unaudited First Quarter 2015 Financial Results
15 May 15
NT 10-Q
Notice of late quarterly filing
15 May 15
8-K
Bioject Reports Unaudited Year-end and Fourth Quarter 2014 Financial Results
1 Apr 15
NT 10-K
Notice of late annual filing
30 Mar 15
8-K
Bioject Reports Unaudited Third Quarter 2014 Financial Results
12 Nov 14
NT 10-Q
Notice of late quarterly filing
12 Nov 14
Latest ownership filings
SC 13D/A
Bioject Medical Technologies Inc
13 Feb 15
SC 13D
Bioject Medical Technologies Inc
31 Jul 14
SC 13D
Bioject Medical Technologies Inc
3 Jul 14
SC 13D/A
Bioject Medical Technologies Inc
3 Jun 14
SC 13D/A
LIFE SCIENCES OPPORTUNITIES FUND II LP
15 Feb 13
SC 13D/A
LIFE SCIENCES OPPORTUNITIES FUND II LP
8 Apr 10
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|